Release date:10/02/2025
VivaChek proudly showcased its cutting-edge innovations at Medlab Middle East 2025, one of the world's leading healthcare and laboratory exhibitions.
Renowned for its comprehensive portfolio of high-quality medical devices, including blood glucose monitoring systems, point-of-care analyzers, PCR kits, and rapid diagnostic tests, VivaChek garnered significant interest from healthcare professionals, distributors, and partners. The event underscored VivaChek's dedication to advancing healthcare through precision diagnostics and reliable, efficient testing solutions.
Our product range spans a variety of diagnostic solutions, each tailored to meet the needs of healthcare providers and enhance patient outcomes. The event provided an invaluable opportunity to engage with key industry stakeholders and expand VivaChek's global presence.
Key Highlights:
· Product Demonstrations: Live demos of VivaChek's advanced testing solutions, including point-of-care analyzers and rapid diagnostic tests, showcased their accuracy, speed, and ease of use.
· Global Network Expansion: New partnerships were forged to extend VivaChek's reach across key regions.
· Innovative Solutions: Attendees praised VivaChek's commitment to innovation in diagnostics, offering a comprehensive range of solutions beyond just diabetes care.
With facilities in China, the U.S., Poland and India, VivaChek continues to provide advanced medical and diagnostic technologies, ensuring global healthcare excellence. The company is present in over 120 countries, and its products continue to contribute to the advancement of the healthcare industry worldwide.